Priya Menon | CureTalks
Priya is Host and Scientific Media Editor at CureTalks/TrialX, an internet radio talk show on healthcare which brings together experts, patients, advocates on the same platform engaging in ‘Discussions for Solutions’. Priya bridges the gap between research and information through her discussions on CureTalks with eminent guests from across the globe. Her interest in communication of science has encouraged her to write extensively presenting a varied view on healthcare and associated domains. Priya is a masters in Microbiology. She also holds degrees in Patent Law, Media Law, and certifications in Writing in Sciences from Stanford University and Management from IIM Bangalore, India. She is also a guest columnist at The Week. Follow (@Cure_talk).
Related Talks
Understanding mRNA Covid-19 Vaccines
Messenger RNA vaccines, also called mRNA vaccines, are some of the first COVID-19 vaccines authorized for use in the United States. mRNA vaccines…
Melflufen for Myeloma: A Deep Dive
The FDA recently granted priority review to a new drug application for melflufen (INN melphalan flufenamide), in combination with dexamethasone. Melflufen is intended…
ASH 2020 Updates: CAR T Cell Therapies in Multiple Myeloma
We kickstart the new year with a discussion on CAR T cells in myeloma treatment with a focus on the CT053, a CAR…
Expanding Male Contraceptive Options: Study Investigating A New Contraceptive Gel
Men who wish to control their fertility currently have limited options. They have to rely on their female partner using contraceptives, use condoms,…
Stem Cell Therapy for COVID-19 related ARDS (Acute Respiratory Distress Syndrome)
Acute respiratory distress syndrome or ARDS is a very serious complication for many patients suffering from COVID-19, and is believed to account for…